ABVC BIOPHARMA, INC., 2026-11-10
A new SEC Form D private-offering notice from Fremont, CA, a $3,387,500 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing plant-derived drugs and medical devices for central nervous system disorders and oncology.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Charter Space Technologies, Inc., 2026-11-10, $2M, El Segundo, CA
- Chickadee Biomedicines, Inc., 2026-11-10, $1M, New York, NY
- OPEN DOORS PARTNERS, LLC, 2026-11-10, $1.5M, Woodside, CA
- Frontier Bio Corp, 2026-11-10, $1M, Hayward, CA
- Quintessent Inc., 2026-11-10, $40.9M, Goleta, CA
- InSitu Biologics, Inc., 2026-11-10, $19.8M, Oakdale, MN
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.